GT Metabolic Solutions Announces Series C Growth Investment Led by J.P. Morgan Life Sciences Private Capital

MINNEAPOLIS — GT Metabolic™ Solutions, Inc. (“the Company” or “GT Metabolic”), a pioneer in the medical device field and the first to receive FDA De Novo grant and 510(k)…

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (financialpost.com)